Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From LivaNova PLC
Special arrangements are needed for VNS for treatment-resistant depression and DBS of the anterior thalamus for refractory epilepsy.
High-profile experts including Anthony Fauci and Adrian Hill share views at the ICMR symposium on progressing safe COVID-19 vaccines backed by ethical trials executed with appropriate scientific rigor. Human challenge studies, "vaccine nationalism" and equitable access were among the key issues deliberated, while India committed to making its coronavirus vaccines and related capabilities available to the world.
Cardiology device firms relied primarily on in-house lobbyists but also recruited external groups to sway lawmakers to adopt favorable positions on reimbursement, COVID-19, international trade and other issues from January-March 2020, says this Medtech Insight analysis.
Also, news on transactions involving Neurocrine/Idorsia, Neurotrope/Metuchen, jCyte/Santen, PTC/Censa, Hoth/Chelexa, Skyhawk/Merck & Co., Orexo/Gaia, Karo/J&J, MaxCyte/Caribou, Mediolanum/ElsaLys, Avectas/ONK
- Implantable Devices
- Other Names / Subsidiaries
- Caisson Interventional, LLC
- CardiacAssist, Inc.
- Cyberonics, Inc., Ela Medical
- ImThera Medical, Inc.
- Sorin Group, Sorin S.p.A.
- Sulzer CarboMedics, Inc.